BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Uslusoy HS, Nak SG, Gülten M. Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis. World J Hepatol 2011; 3(8): 219-227 [PMID: 21954411 DOI: 10.4254/wjh.v3.i8.219]
URL: https://www.wjgnet.com/1007-9327/full/v3/i8/219.htm
Number Citing Articles
1
Frhaan M. Zahrawi, Wajahat Z. Mehal. Letter to the Editor: Concerns regarding the use of fatty liver index in studies of lean NAFLDHepatology 2024; 79(5): E129 doi: 10.1097/HEP.0000000000000754
2
Halina Cichoż-Lach, Krzysztof Celiński, Beata Prozorow-Król, Jarosław Swatek, Maria Słomka, Tomasz Lach. The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver diseaseMedical Science Monitor 2012; 18(12): CR735 doi: 10.12659/MSM.883601
3
Limin Cao, Yu An, Huiyuan Liu, Jinguo Jiang, Wenqi Liu, Yuhan Zhou, Mengyuan Shi, Wei Dai, Yanling Lv, Yuhong Zhao, Yanhui Lu, Liangkai Chen, Yang Xia. Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysisBMC Medicine 2024; 22(1) doi: 10.1186/s12916-024-03315-0
4
Qing Ye, Biyao Zou, Yee Hui Yeo, Jie Li, Daniel Q Huang, Yuankai Wu, Hongli Yang, Chuanli Liu, Leslie Y Kam, Xiang Xuan Eunice Tan, Nicholas Chien, Sam Trinh, Linda Henry, Christopher Donald Stave, Tetsuya Hosaka, Ramsey C Cheung, Mindie H Nguyen. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysisThe Lancet Gastroenterology & Hepatology 2020; 5(8): 739 doi: 10.1016/S2468-1253(20)30077-7
5
Behrooz Kalidari, Mohsen Mahmoudieh, Hamid Melali, Mehdi Nazari Moghadam, Mohsen Kolahdouzan. Predictive Factors of Steatosis and Non-Alcoholic Steatohepatitis in Morbidly Obese Patients Undergoing Bariatric SurgeryHepatitis Monthly 2017; 17(11) doi: 10.5812/hepatmon.14088
6
Kang Li, Ling Qin, Sanjie Jiang, Ang Li, Chi Zhang, Guihai Liu, Jianping Sun, Huanqing Sun, Yan Zhao, Ning Li, Yonghong Zhang. The signature of HBV-related liver disease in peripheral blood mononuclear cell DNA methylationClinical Epigenetics 2020; 12(1) doi: 10.1186/s13148-020-00847-z
7
Jingjing Jiao, Kohtaro Ooka, Holger Fey, Maria Isabel Fiel, Adeeb H. Rahmman, Kensuke Kojima, Yujin Hoshida, Xintong Chen, Tatiana de Paula, Diana Vetter, David Sastre, Ka Hin Lee, Youngmin A. Lee, Meena Bansal, Scott L. Friedman, Miriam Merad, Costica Aloman. Interleukin-15 receptor α on hepatic stellate cells regulates hepatic fibrogenesis in miceJournal of Hepatology 2016; 65(2): 344 doi: 10.1016/j.jhep.2016.04.020
8
Fezzeh Elyasinia, Seyed Mehdi Jalali, Soroush Zarini, Ehsan Sadeghian, Ahmadreza Sorush, Amirhossein Pirouz. The Effect of Laparoscopic Sleeve Gastrectomy and Gastric Bypass Surgery on Non-Alcoholic Steatohepatitis in Iranian Patients with ObesityMiddle East Journal of Digestive Diseases 2021; 13(3): 200 doi: 10.34172/mejdd.2021.226
9
Paula Cenira Senger de CASTRO, Helen Caroline Perussolo ALBERTON, Maria Lucia Alves PEDROSO, Daphne Benatti Gonçalves MORSOLETTO, Alcindo PISSAIA JUNIOR, Cláudia Alexandra Pontes IVANTES. EVALUATION OF PROGRESSION OF HEPATIC FIBROSIS IN A GROUP OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANIED FOR 10 YEARSArquivos de Gastroenterologia 2019; 56(3): 256 doi: 10.1590/s0004-2803.201900000-48
10
Oumarou Nabi, Nathanaël Lapidus, Jerome Boursier, Victor de Ledinghen, Jean-Michel Petit, Sofiane Kab, Adeline Renuy, Marie Zins, Karine Lacombe, Lawrence Serfaty. Reply: Concerns regarding the use of Fatty Liver Index in studies of lean NAFLDHepatology 2024; 79(5): E130 doi: 10.1097/HEP.0000000000000755
11
Giorgio Cavallini, Gianni Paulis. Improvement of Chronic Peyronie's Disease Symptoms After Diabetic Compensation: A Retrospective StudyUrology 2013; 81(4): 794 doi: 10.1016/j.urology.2012.12.030
12
Johannes Wilhelm Rey, Antje Jahn-Eimermacher, Veronika Doernberger, Ana Paula Barreiros, Markus Krupp, Arthur Hoffman, Ralf Kiesslich, Martina Müller-Schilling, Peter Robert Galle, Andreas Teufel. To Biopsy or Not to Biopsy: Evaluation of a Large German Cohort of Patients with Abnormal Liver Tests of Unknown EtiologyDigestion 2014; 89(4): 310 doi: 10.1159/000362404
13
Marcelo Leite Vieira Costa, Roberto César Pereira Lima-Júnior, Karoline Sabóia Aragão, Raul Pinheiro Medeiros, Raphael Dias Marques-Neto, Lucas de Sá Grassi, Leandro Linhares Leite, Lorena Guimaraes Nunes, José Wilson Benevides de Mesquita Neto, Gerly Anne de Castro Brito, Marcellus Henrique Loiola Pontes de Souza, Paulo Roberto Carvalho de Almeida, Ronaldo Albuquerque Ribeiro. Chemotherapy-associated steatohepatitis induced by irinotecan: a novel animal modelCancer Chemotherapy and Pharmacology 2014; 74(4): 711 doi: 10.1007/s00280-014-2434-8
14
Rodrigo Bremer Nones, Cláudia Pontes Ivantes, Maria Lucia Alves Pedroso. Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?Archives of Endocrinology and Metabolism 2017; 61(3): 276 doi: 10.1590/2359-3997000000233
15
Celso Nilo Didoné Filho, Cleiton Jonei Reginatto, Cláudia Alexandra Pontes Ivantes, Rodrigo Strobel, Ana Paula Percicote, Marcio Petenusso, Cicero Jordan R. Sobreira da Silva, Cicero Jonas R. Benjamim, Rosana Bento Radominski. Comparison between non-invasive methods and liver histology to stratify liver fibrosis in obese patients submitted to bariatric surgeryObesity Research & Clinical Practice 2021; 15(2): 152 doi: 10.1016/j.orcp.2021.02.004
16
Mari Lahelma, Panu K. Luukkonen, Sami Qadri, Noora Ahlholm, Susanna Lallukka-Brück, Kimmo Porthan, Anne Juuti, Henna Sammalkorpi, Anne K. Penttilä, Johanna Arola, Marju Orho-Melander, Hannele Yki-Järvinen. Assessment of Lifestyle Factors Helps to Identify Liver Fibrosis Due to Non-Alcoholic Fatty Liver Disease in ObesityNutrients 2021; 13(1): 169 doi: 10.3390/nu13010169